Wilson Sonsini Goodrich & Rosati and Cooley advised Kura Oncology. Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision...
You must be a Standard 1 Year member to access this content.
Cooley LLP is serving as U.S. legal advisor, and Ogier is serving as Cayman Islands legal advisor to PSI Group Holdings Ltd in the transaction, while...
You must be a Standard 1 Year member to access this content.
Cooley advised SystImmune on the transaction. SystImmune announced its exclusive license and collaboration agreement with Bristol Myers Squibb (NYSE: BMY) for SystImmune’s BL-B01D1. Under the terms of...
You must be a Standard 1 Year member to access this content.
Cooley acted as U.S. legal advisor to Vietnam Sunergy Cell Company, and Robinson & Cole acted as U.S. legal advisor to Blue World. Vietnam Sunergy Cell...
You must be a Standard 1 Year member to access this content.
Cooley represented Turnstone, and Latham & Watkins represented the underwriters in the IPO. Turnstone Biologics Corp. (Nasdaq: TSBX) announced the pricing of its upsized initial public...
You must be a Standard 1 Year member to access this content.
Cooley advised Zion Pharma Limited on the deal. Zion Pharma Limited, a Chinese biotechnology company focused on the development of brain-penetrable compounds, announced the acquisition of its...
You must be a Standard 1 Year member to access this content.
Cooley advised SCYNEXIS on the deal. SCYNEXIS announced its exclusive license agreement with GSK for Brexafemme. The exclusive license agreement gives GSK rights to commercialize SCYNEXIS’ ibrexafungerp...
You must be a Standard 1 Year member to access this content.
Cooley advised SoundHound AI on the deal. SoundHound AI, a leader in voice artificial intelligence, announced the closing of a new $125 million loan facility from...
You must be a Standard 1 Year member to access this content.
Cooley advised Redx Pharma on the deal while Ropes & Gray has advised Jounce Therapeutics, Inc. Redx Pharma, a UK clinical-stage biotechnology company, announced its all share...
You must be a Standard 1 Year member to access this content.
Cooley LLP represented Structure Therapeutics, while Latham & Watkins LLP represented the underwriters in the offering. Structure Therapeutics, a clinical-stage global biopharmaceutical company, announced its $185.3 million...
You must be a Standard 1 Year member to access this content.
Cooley advised Justin Bieber on the deal. Justin Bieber announced a $200 million deal to sell his music rights to Blackstone-backed Hipgnosis Songs Capital. The deal is...
You must be a Standard 1 Year member to access this content.
YPOG advised Atomico on the deal. Taylor Wessing advised DeepL. Cooley, GLNS and SSH Rechtsanwälte advised IVP. DeepL, a Cologne, Germany-based artificial intelligence startup that provides...
You must be a Standard 1 Year member to access this content.
